Jones Trading Starts AbCellera Biologics (ABCL) at Buy

Jones Trading analyst Debanjana Chatterjee initiates coverage on AbCellera Biologics (NASDAQ: ABCL) with a Buy rating and a price target of $11.00.

For an analyst ratings summary and ratings history on AbCellera Biologics click here. For more ratings news on AbCellera Biologics click here.

Shares of AbCellera Biologics closed at $3.43 yesterday.

You May Also Be Interested In

• These Have the Market Hot Zone Catalysts and Setups
• Northrop Grumman gets $158.8 million contract modification
• Western Union's Intermex deal gets NY approval, California suspended